Clinical Trial Update: Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a targeted, dose-escalation busulfan-etoposide conditioning regimen for acute myeloid leukemia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• Etoposide (Etoposide)

Snippet

Sponsor: University of California, San Francisco | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED